{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:40:10Z","timestamp":1750534810459,"version":"3.41.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 77-year-old man presented with progressive deterioration of physical capacity after successful percutaneous coronary intervention of known chronic coronary syndrome. Transthoracic echocardiography revealed hypertrophy of the left ventricle, and electrocardiogram showed low QRS voltage in all leads. <jats:sup>99m<\/jats:sup>Tc-DPD scintigraphy was conducted to differentiate etiology such as amyloidosis and revealed increased cardiac tracer uptake in the left (grade 3) and right ventricle. Immunofixation showed no signs of paraproteinemia or Bence-Jones proteinuria. Thus, biventricular involvement of ATTR-cardiomyopathy was identified by <jats:sup>99m<\/jats:sup>Tc-DPD scintigraphy. This approach should be considered if hypertrophic phenotype is present in patients with persistent deterioration of physical capacity not attributable to coronary artery disease.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004789","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T22:14:57Z","timestamp":1692224097000},"page":"888-889","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Divergent Findings in the Diagnosis of ATTR-CM Using Common Cardiac Diagnostics and 99mTc-DPD Scintigraphy"],"prefix":"10.1097","volume":"48","author":[{"given":"Sophie C.","family":"Kunte","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie K.","family":"Schwarting","sequence":"additional","affiliation":[{"name":"Cardiology, University Hospital, LMU Munich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Holzgreve","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"W\u00f6hrle","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Unterrainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena M.","family":"Unterrainer","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","year":"2009","journal-title":"Circulation"},{"issue":"Suppl 2","key":"bib3-20250621","first-page":"s30","article-title":"Cardiac amyloidosis","volume":"18","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from a (AA) to T (ATTR): a review","volume":"289","year":"2021","journal-title":"J Intern Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","article-title":"Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness","volume":"27","year":"2022","journal-title":"Heart Fail Rev"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques","volume":"21","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC Review Topic of the Week","volume":"75","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","article-title":"Diagnostic imaging of cardiac amyloidosis","volume":"17","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e18905","DOI":"10.1097\/MD.0000000000018905","article-title":"99mTc-DPD scintigraphy and SPECT\/CT in patients with AL and ATTR type amyloidosis: potential clinical implications","volume":"99","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: a test in evolution","volume":"14","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"bib12-20250621","first-page":"159","article-title":"Amyloidosis-the diagnosis and treatment of an underdiagnosed disease","volume":"117","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/RLU.0000000000004597","article-title":"Feasibility of left ventricle ejection fraction calculation using electrocardiographically gated SPECT acquisition of 99m Tc-HDP bone scintigraphy in cardiac amyloidosis","volume":"48","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:05Z","timestamp":1750532465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004789","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,8,11]]}}}